Amid growing fears of antimicrobial-resistance, NHS payment scheme aims for pharma to tackle superbugs
April 12, 2022Manufacturing and Production
NICE has shared that cefiderocol, and ceftazidime/avibactam, have the potential to save lives. The two medications, which fight drug-resistant superbugs, …
VR solution for personalised treatment and surgery guidance to spine surgeons
April 12, 2022Manufacturing and Production
Seymourpowell and Axis Spine Technologies have announced a virtual reality (VR) solution allowing surgeons to evaluate and develop spinal implants …
SMC accepts Inrebic for treatment of splenomegaly and myelofibrosis
April 12, 2022The SMC has accepted Inrebic (fedratinib) for use witin NHS Scotland, for the treatment of disease-related splenomegaly (enlarged spleen). It …
Recipharm announces closing of acquisitions of two major CDMOs
April 11, 2022Sales and Marketing
Recipharm has announced the closing of its acquisitions of advanced therapy CDMO Arranta Bio and virotherapy CDMO Vibalogics. The acquisitions …
Innovative therapy ‘tricks’ and destroys cancer cells
April 11, 2022Sales and Marketing
A novel therapy studied at the Medical College of Wisconsin (MCW) Cancer Centre is headed for clinical trial in patients …
World leaders pledge $4.8 billion in 2022 Break COVID Now Summit
April 11, 2022Sales and Marketing
World leaders in Germany, Ghana, Indonesia, and Senegal came together in the 2022 Break COVID Now Summit, co-hosted by vaccine …
‘Killer’ immunotherapy shows early promise
April 11, 2022Sales and Marketing
A first of its kind immunotherapy which uses the immune system’s ‘natural killer cells’ could offer potential against a range …
NICE publishes guidance for atopic dermatitis treatments
April 8, 2022Medical Communications
Abrocitinib, upadacitinib, and tralokinumab are not recommended for treating moderate to severe atopic dermatitis. The recommendation does not affect patients …
First-of-its-kind vaccine manufacturing facility shipped to Africa
April 8, 2022Medical Communications
KeyPlants announced the shipping a first-of-its-kind vaccine manufacturing filling facility to Senegal, in West Africa.
Acadia seeks first-ever FDA approval in Rett Syndrome
April 8, 2022Medical Communications
Acadia has presented an update on its Phase III LAVENDER study of trofinetide for Rett Syndrome at the American Academy …
Kintor’s antiviral shows protection in mild-to-moderate COVID-19
April 7, 2022Business Services
Kintor Pharmaceutical, based in Suzhou, China, has announced top-line results from its Phase III MRCT trial of proxalutamide in outpatients …
Blood clot risk higher for six months after having COVID-19
April 7, 2022Business Services
A study from Sweden suggests that after a COVID-19 infection, there is an increased risk of developing a serious blood …
Eligible patients in the UK granted early access for radioligand therapy in advanced prostate cancer
April 7, 2022Business Services
Advanced Accelerator Applications (AAA), a Novartis company, has announced that eligible patients in the UK have been granted early access …
Global Paediatric Drug Development Centre of Excellence opened in Dublin’s North Dock
April 7, 2022Business Services
Gilead Sciences announced on April 6th the formal opening of its Dublin city centre office, focused on developing new paediatric …
Nine more COVID-19 symptoms added to list
April 6, 2022Research and Development
Nine new symptoms, including sore throat, fatigue, and headache, have been added to the official list of COVID-19 symptoms on …
UK Government accused of failing to address cancer staff shortages
April 6, 2022Research and Development
MPs have warned that urgent steps are needed to prevent the UK from losing gains made in recent years on …
New variant, Omicron XE, detected in UK
April 6, 2022Research and Development
A new sub-variant of Omicron has been found in the UK, as the country experiences a new surge of COVID-19.The …
Race to deliver HIV drugs to Ukraine
April 6, 2022Research and Development
WHO is to supply thousands of antiretroviral drugs to Ukraine for patients living with HIV over the next year. UNAIDS, …
European Commission approves treatment of unresectable uveal melanoma
April 5, 2022Manufacturing and Production
Immunocore Holdings has announced that the European Commission has approved KIMMTRAK® (tebentafusp) for the treatment of HLA-A*02:01-positive adult patients with …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
